Effectiveness of Sarivadi Lauha in the management of vatarakta(Gout)

Effectiveness of Sarivadi Lauha in the symptomatic management of Vatarakta(Gouty Arthritis)An Exploratory Clinical Study - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108812

Enrollment

Registered

2026-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group of 20-60 years of either sex present with clinical features of Vatarakta. Well Diagnosed and confirmed case of Vatarakta (Gout). Patients having serum uric acid levels of more than 6 mg/dl with or without any associated features like joint pain and inflammation. Patients willing to provide informed consent.

Exclusion criteria

Exclusion criteria: Pregnancy/Lactation: Pregnant or lactating women. Patients with chronic renal failure, diabetes mellitus, hypertension uncontrolled by medication. Patients with autoimmune arthritis (Arthritis like Rheumatoid arthritis, Osteoarthritis, Ankylosing spondylitis, Infective arthritis etc. Patients with known hypersensitivity to any component of the trial drug.

Design outcomes

Primary

Measure	Time frame
changes in the clinical sign and symptoms (Subjective parameter ) of vatarakta(goutyarthritis). Timepoint: 15th day 30th day 45th day	—

Secondary

Measure	Time frame
changes in the objective parameters.Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr kavita

Post graduate Institute of Ayurveda Jodhpur

bkmudga19@gmail.com9878897127

Outcome results